4D Molecular Therapeutics filed the paperwork for a $100 Million IPO on 9/30/19. The Emeryville, CA based company is focused on developing genetic therapies for both rare and large market diseases. The company will trade on NASDAQ under the symbol “DDDD.”
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,